University of Tennessee

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Tennessee sits in the top decile of US sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count).

96 total trials 12 currently recruiting 71 completed top decile by trial count

University of Tennessee: 96 sponsored US clinical trials, 12 recruiting.

University of Tennessee sponsors 96 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 71 completed. 14 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Lung Disease, with 2 trials.

Top-decile sponsor footprint

University of Tennessee ranks in the top decile of sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 67/100

71 of 78 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

96 total, page 2 of 2

COMPLETED NA

Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty

NCT02597673
COMPLETED

Obstetrical Repository of Biological Materials

NCT02429362
COMPLETED NA

Preservation of Ovarian Tissue and Chemo-Radiotherapy

NCT02429349
TERMINATED Phase 4

Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures

NCT02400112
COMPLETED Phase 4

Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis

NCT02371941
COMPLETED NA

Caffeine Disposition After Inhalation

NCT02184104
COMPLETED NA

Electromyostimulation and Strength Walking for Knee Injuries

NCT02065518
COMPLETED NA

Dissemination of the Look Ahead Weight Management Treatment in the Military

NCT02063178
TERMINATED

Utilization of Leukocyte Esterase in the Diagnosis of Pediatric Joint Infections

NCT02032732
COMPLETED NA

Human Milk Fortification in Very Low Birth Neonates

NCT01988792
COMPLETED NA

Pathobiology and Reversibility of Prediabetes in a Biracial Cohort

NCT02027571
COMPLETED NA

Effects of a Minimal-Contact Lifestyle Intervention on Physical Activity, Diet, and Body Weight

NCT02008071
COMPLETED NA

A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response

NCT01301001
COMPLETED Phase 1

Alcohol Inhibits Drug Metabolism by Carboxylesterases

NCT01708369
COMPLETED

Tissue Samples and Bodily Fluid Specimens Banking

NCT02431884
COMPLETED

Characteristics of Women With Reproductive Concerns

NCT02429336
COMPLETED NA

MRSA in a Trauma Population: Does Decolonization Prevent Infection?

NCT01820455
COMPLETED Phase 1

Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis

NCT01088607
COMPLETED Phase 3

Savella in Treatment for Provoked Vestibulodynia

NCT01304589
COMPLETED Phase 1

Physical Activity and Leisure-time Study (PALS)

NCT01342471
COMPLETED NA

Laser Photocoagulation in Twin to Twin Transfusion Syndrome

NCT02506049
COMPLETED NA

Behavioral Contract Adherence Intervention

NCT01739803
TERMINATED NA

Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin

NCT02027532
COMPLETED NA

Strength, Pain and Function in Operation Iraqi Freedom/Operation Enduring Freedom Amputees: A Nurse-Managed Program

NCT00942890
COMPLETED Phase 1

Radioimmunoimaging of AL Amyloidosis

NCT00807872
COMPLETED Phase 1

Radioimmunoimaging of Light Chain (AL) Amyloidosis

NCT01815086
COMPLETED Phase 1

Radioimmunoimaging of AL Amyloidosis

NCT01409148
COMPLETED NA

A Pilot Study of Pulmonary Function in Dysphagic Infants

NCT00831038
COMPLETED NA

Dairy Attenuation of Metabolic Disease

NCT01266330
COMPLETED NA

Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study)

NCT00632411
COMPLETED NA

The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting

NCT00689013
COMPLETED Phase 1

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

NCT00547365
COMPLETED NA

Dairy Modulation of Oxidative and Inflammatory Stress in Overweight and Obese Subjects

NCT00948038
TERMINATED Phase 2

Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications

NCT00427609
COMPLETED Phase 3

Early Versus Interval Appendectomy for Ruptured Appendicitis in Children

NCT00435032
COMPLETED Phase 2

Team PLAY (Positive Lifestyles for Active Youngsters)

NCT00528164
COMPLETED NA

Evaluation of Etomidate on Adrenal Function in Trauma Patients

NCT00462644
COMPLETED NA

Prolonged Smoking Cessation Using Prescription Step Care

NCT00170079
COMPLETED NA

A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia

NCT00374114
COMPLETED NA

Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals

NCT00308763
COMPLETED NA

Role of Dairy Products in Weight Maintenance

NCT00686426
COMPLETED NA

Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates

NCT00037752
COMPLETED Phase 1

Magnesium Supplementation to Prevent Bone Loss

NCT00346658
COMPLETED Phase 2

Oral Collagen for Rheumatoid Arthritis

NCT00000401
COMPLETED Phase 2

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

NCT00003580
COMPLETED Phase 2

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

NCT00003007
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 8
Phase 2 8
Phase 3 5
Phase 4 9

Therapeutic Areas

Chronic Lung Disease 2
Postoperative Pain 2
Smoking Cessation 2
Weight Loss 2
Infertility Involuntary 1
Secondary Infertility 1
Endocrine Disorders of Female Reproductive System 1
Subacute Low Back Pain 1
Proximal Muscle Lengthening 1
Proximal Muscle Strength 1

What is open in the University of Tennessee pipeline

12 recruiting of 96 indexed (13% open); 71 completed (74%).

Phase mix: 14 late (III/IV) vs 16 early (I/II) (balanced across stages).

Top condition: Chronic Lung Disease (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Tennessee: open-pipeline peers nationwide

Peers matched on 96 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Tennessee sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080100120 0%5%10%15%20% Total trials Recruiting share University of TennesseeMasimo CorporationUniversity of Mississippi Medical CenterArkansas Children's Hospital Research InstituteAdventHealthAddario Lung Cancer Medical InstituteAmerican UniversityAnnexonAnsun Biopharma
University of Tennessee sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Tennessee sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 96 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Tennessee page

96 registered trials is a research-attention snapshot, not an endorsement of University of Tennessee or any single study.

  • 12 of University of Tennessee's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Chronic Lung Disease is the condition University of Tennessee studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Lung Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Tennessee pipeline card: 96 registered trials from official public datasets.Report a data error.